IMARC Group, a leading market research company, has recently releases report titled “Pharmaceutical Drug Delivery Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.” The study provides a detailed analysis of the industry, including the global pharmaceutical drug delivery market share, growth, size, trends, and forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
Industry Overview of Pharmaceutical Drug Delivery
Pharmaceutical drug delivery is the process of transporting and administering pharmaceutical compounds to the targeted areas within the human body. It encompasses a wide range of technologies designed to enhance the effectiveness and safety of medications. It involves the art and science of getting therapeutic agents to the specific site of action in the body, ensuring they exert their desired effects while minimizing side effects. It helps improve patient compliance and convenience by providing more convenient and user-friendly options. It can enhance bioavailability by protecting the drug from degradation and facilitating its absorption.
How Big Is the Pharmaceutical Drug Delivery Market?
The global pharmaceutical drug delivery market size reached US$ 1,325 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 1,848 Billion by 2028, exhibiting a growth rate (CAGR) of 5.5% during 2023-2028.
Request Sample Copy of This Report: https://www.imarcgroup.com/pharmaceutical-drug-delivery-market/requestsample
What are the growth prospects and trends in the pharmaceutical drug delivery industry?
The rising shift toward patient-centric healthcare represents one of the key factors influencing the market positively. Patients now demand more personalized, convenient, and less invasive treatment options. Drug delivery technologies, such as wearable devices and self-administered injectables, meet this demand, enhance patient compliance, and improve overall treatment experiences.
Additionally, the continuous rise of biologic drugs, including monoclonal antibodies and gene therapies, is driving the need for advanced drug delivery systems. These therapies often require precise delivery to target cells or tissues, driving innovation in nanotechnology and controlled-release systems. Apart from this, the rising prevalence of various chronic diseases, such as diabetes, cardiovascular diseases, and cancer, is driving the need for long-term medication. Drug delivery systems, such as implantable devices and extended-release formulations, are increasingly used in managing these conditions effectively.
Furthermore, rapid advancements in materials science, nanotechnology, and three-dimensional (3D) printing are enabling the development of novel drug delivery platforms. Nanoparticles, liposomes, and hydrogels are enhancing drug stability, bioavailability, and controlled release. Moreover, various regulatory agencies, such as the FDA and EMA, are providing support for innovative drug delivery technologies. Expedited approvals and streamlined pathways for innovative drug delivery systems are encouraging pharmaceutical companies to invest in these solutions. Besides this, the expanding aging population is driving demand for geriatric-friendly drug delivery systems. These systems focus on ease of use, dosing accuracy, and minimizing adverse effects, aligning with the unique needs of older patients.
What is included in market segmentation?
The report has segmented the market into the following categories:
Breakup by Route of Administration:
Oral Drug Delivery
Injectable Drug Delivery
Topical Drug Delivery
Ocular Drug Delivery
Pulmonary Drug Delivery
Implantable Drug Delivery
Transmucosal Drug Delivery
Nasal Drug Delivery
Breakup by Application:
Infectious Diseases
Cancer
Cardiovascular Diseases
Diabetes
Respiratory Diseases
Central Nervous System Disorders
Autoimmune Diseases
Others
Breakup by End User:
Hospitals
Ambulatory Surgery Centers
Home Care Settings
Diagnostic Centers
Others
Breakup by Region:
North America: (United States, Canada)
Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
Latin America: (Brazil, Mexico, Others)
Middle East and Africa
Who are the key players operating in the industry?
The report covers the major market players including:
AbbVie Inc.
Amgen Inc.
AstraZeneca plc
Becton Dickinson and Company
Eli Lilly and Company
GSK plc
Johnson & Johnson
Merck KGaA
Novartis AG
Pfizer Inc.
Sanofi S.A.
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC Group’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Email: sales@imarcgroup.com
Follow us on Twitter: @imarcglobal
LinkedIn: https://www.linkedin.com/company/imarc-group/mycompany/
